The glucagon component enhances hepatic function, the GLP-1 component reduces systemic inflammation, and the GIP component improves metabolic signaling broadly
This extended duration of action made exendin-4 a promising candidate for therapeutic development
In the Phase 2 trial protocol, participants reached the 12mg maximum dose at week 20 after five escalation steps (1mg, 2mg, 4mg, 8mg, 12mg), each held for four weeks
We look forward to additional cardiovascular outcome trials in patients with obesity. The trial was sponsored by Novo Nordisk, the company that markets semaglutide
What you need Gather everything before you start
GLP-1 Pills A newer option is the GLP-1 pill version of Wegovy, released in early 2026